05May
[Webinar] Diagnostics, Antibody Testing and Vaccines: Global Outlook on Life Sciences COVID-19 Advances and Evolving Deal Trends - May 7th, 11:00 am - 12:15 pm EDT
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team will examine the current...
By:
McDermott Will & Emery
Related
There is a lot of confusion about how the California Consumer Privacy Act (CCPA) will impact Califor...
Read More >
The National Labor Relations Board announced a number of changes to its representation election rule...
Read More >
Well it’s been quite a year. Thank goodness it’s almost over! We started it (much as we have start...
Read More >
In Pena v. Honeywell International, Inc., issued on July 22, 2019, the U.S. Court of Appeals for the...
Read More >
On February 6, 2020, Nicaraguan Ministry of Labor issued the Ministerial Agreement number ALTB-01-02...
Read More >
Whereas COVID-19 is likely to delay review timelines of many M&A deals, it may also make some approv...
Read More >